drug development
A New Chlamydia Vaccine on the Horizon
Sexually transmitted diseases (STDs) such as hepatitis B, chlamydia, syphilis, and gonorrhea are currently on the rise in many countries…
Are M&As the Key to Securing Growth in the Orphan Drugs Sector?
The orphan drug market can be an alluringly lucrative sector. Most big pharma corporations inherit these specialty business units through mergers…
Pharma Technology Focus: Scottish pharma gets a health check
Pharma Technology Focus is now available on all devices. Read it for free here In July last year, the supply of…
Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus
Pharma Technology Focus is now available on all devices. Read it for free here We look into the safety issues associated…
Find out about the foundation for the first drugs using microbiome bacteria in the latest issue of Pharma Technology Focus
Pharma Technology Focus is now available on all devices. Read it for free here. In this issue we find out…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Pharma Technology Focus – Issue 77
Pharma Technology Focus is now available on all devices. Read it for free here The top pharmaceutical companies have been…
Pharma Technology Focus – Issue 76
Pharma Technology Focus is now available on all devices. Read it for free here Significant progress has been made to roll…
Pharma Technology Focus – Special Issue
Pharma Technology Focus is now available on all devices. Read it for free here. Personalised medicine has been hailed as a…
Pharma Technology Focus – Issue 74
Pharma Technology Focus is now available on all devices. Read it for free here. Trust in big pharma has never…
GSK invests $300m in 23andMe under drug development deal
GlaxoSmithKline (GSK) has formed a multi-year alliance with genetics firm 23andMe to carry out research and development for new medicines…